))
Episode 16: Antibiotic Resistance: The Patient Experience
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on February 27, 2024 04:28 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 337444518 series 3381207
Sisällön tarjoaa Gunnar Esiason. Gunnar Esiason tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
The State of Health is back after a brief summer vacation. This week, Emma D'Agostino, PhD joins the show to talk with Gunnar about their jointly written opinion piece that appeared in The Hill in mid-August entitled: New bipartisan legislation can encourage needed antibiotic development, where they called for bipartisan reform of the antibiotic market. Gunnar and Emma lean on past personal experience with antibiotic resistant infections, their frustrations with the lack of new options and their hopes for how policymakers can reach across the aisle to address the broken incentives at the heart of the reimbursement market that is largely specific to antibiotics.
The episode is the first in an ongoing series about antibiotics and the quest to bring novel technologies to combat the rising threat of antimicrobial resistance.
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy
Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
23 jaksoa
Jaa
